These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6347833)

  • 1. Double-blind comparison of the efficacy, tolerance and safety of tioconazole and placebo in patients with vaginal candidiasis and the assessment of systemic absorption.
    Artner J; Fuchs G
    Gynakol Rundsch; 1983; 23 Suppl 1():20-4. PubMed ID: 6347833
    [No Abstract]   [Full Text] [Related]  

  • 2. Open comparison of the efficacy, toleration and safety of tioconazole and econazole in the 3-day treatment of vaginal candidiasis.
    Krohn K; Vinnerberg A
    Gynakol Rundsch; 1983; 23 Suppl 1():29-32. PubMed ID: 6347834
    [No Abstract]   [Full Text] [Related]  

  • 3. Open comparison of the efficacy, toleration and safety of tioconazole cream used for either 3- or 6-day treatment of patients with vaginal candidiasis.
    Oittner R
    Gynakol Rundsch; 1983; 23 Suppl 1():33-6. PubMed ID: 6873745
    [No Abstract]   [Full Text] [Related]  

  • 4. Butoconazole vaginal cream in the treatment of vulvovaginal candidiasis. Comparison with miconazole nitrate and placebo.
    Brown D; Henzl MR; LePage ME; Tsao LL; Izu AE; Walker KA; Adamson GD; Droegmuller W
    J Reprod Med; 1986 Nov; 31(11):1045-8. PubMed ID: 3543342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tioconazole in the treatment of vaginal candidiasis. An international clinical research program.
    Henderson JT; Neilson W; Wilson AB; Jevons S
    Gynakol Rundsch; 1983; 23 Suppl 1():42-60. PubMed ID: 6873747
    [No Abstract]   [Full Text] [Related]  

  • 6. Open studies of the efficacy, tolerance, systemic absorption and vaginal persistence following a single application of tioconazole ointment in the treatment of patients with vaginal candidiasis.
    Artner J; Fuchs G
    Gynakol Rundsch; 1983; 23 Suppl 1():12-9. PubMed ID: 6873743
    [No Abstract]   [Full Text] [Related]  

  • 7. Open comparison of the efficacy, toleration and safety of tioconazole cream and econazole ovules used in the 3-day treatment of patients with vaginal candidiasis.
    Cohen J
    Gynakol Rundsch; 1983; 23 Suppl 1():25-8. PubMed ID: 6873744
    [No Abstract]   [Full Text] [Related]  

  • 8. Single-dose tioconazole compared with 3-day clotrimazole treatment in vulvovaginal candidiasis.
    Stein GE; Gurwith D; Mummaw N; Gurwith M
    Antimicrob Agents Chemother; 1986 Jun; 29(6):969-71. PubMed ID: 3524439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Butoconazole for vulvovaginal candidiasis.
    Med Lett Drugs Ther; 1986 Jul; 28(717):68. PubMed ID: 3523181
    [No Abstract]   [Full Text] [Related]  

  • 10. [A clinical study of cyclopyroxolamine versus clotrimazole in the treatment of mycotic vulvovaginitis].
    Giannoni M; Pollastro M; Jacobellis M
    Minerva Med; 1990; 81(7-8):555-9. PubMed ID: 2199853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of single administration with an ovule of 600 mg fenticonazole versus a 500 mg clotrimazole vaginal pessary in the treatment of vaginal candidiasis.
    Wiest W; Azzollini E; Ruffmann R
    J Int Med Res; 1989; 17(4):369-72. PubMed ID: 2676652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of vaginal candidiasis using a three-day course of Tioconazole: a preliminary report.
    Rachagan SP; Sivanesaratnam V
    Med J Malaysia; 1986 Mar; 41(1):30-2. PubMed ID: 3796344
    [No Abstract]   [Full Text] [Related]  

  • 13. Tioconazole in the treatment of vaginal candidosis.
    Schaetzing A
    Mycoses; 1988 Nov; 31(11):584-9. PubMed ID: 3216880
    [No Abstract]   [Full Text] [Related]  

  • 14. Topical tioconazole versus systemic ketoconazole treatment of vaginal candidiasis.
    Rohde-Werner H
    J Int Med Res; 1984; 12(5):298-302. PubMed ID: 6094282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The therapy of vulvovaginal mycoses with the antimycotic monistat (author's transl)].
    Branger F
    Schweiz Rundsch Med Prax; 1974 Feb; 63(7):191-3. PubMed ID: 4411222
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of butoconazole nitrate in the treatment of vulvo-vaginal candidiasis compared with clotrimazol and isoconasol.
    López Fiesco A; Ayala Ruíz A; Romo LM; Delgado MD; Zamora G
    Proc West Pharmacol Soc; 1993; 36():185-8. PubMed ID: 8378376
    [No Abstract]   [Full Text] [Related]  

  • 17. The clinical and cytological assessment of tioconazole in vulvo-vaginal candidiasis.
    Robertson WH
    Ala J Med Sci; 1985 Jul; 22(3):305-10. PubMed ID: 4025721
    [No Abstract]   [Full Text] [Related]  

  • 18. Drugs for vulvovaginal candidiasis.
    Med Lett Drugs Ther; 2001 Jan; 43(1095):3-4. PubMed ID: 11151090
    [No Abstract]   [Full Text] [Related]  

  • 19. Butoconazole nitrate.
    Tatum DM; Eggleston M
    Infect Control Hosp Epidemiol; 1988 Mar; 9(3):122-4. PubMed ID: 3280665
    [No Abstract]   [Full Text] [Related]  

  • 20. Tioconazole. A review of its antimicrobial activity and therapeutic use in superficial mycoses.
    Clissold SP; Heel RC
    Drugs; 1986 Jan; 31(1):29-51. PubMed ID: 3510114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.